Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-10-31
2006-10-31
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S315000, C514S327000, C514S331000, C546S022000, C546S024000, C546S217000, C546S233000, C546S234000, C546S242000, C546S247000
Reexamination Certificate
active
07129228
ABSTRACT:
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.
REFERENCES:
patent: 3164600 (1965-01-01), Janssen et al.
patent: 3655675 (1972-04-01), Carabateas
patent: 3998834 (1976-12-01), Janssen et al.
patent: 4138492 (1979-02-01), Noverola et al.
patent: 4167574 (1979-09-01), Janssens
patent: 4584303 (1986-04-01), Huang et al.
patent: 4791120 (1988-12-01), Lin et al.
patent: 4791121 (1988-12-01), Kudzma et al.
patent: 4831192 (1989-05-01), Lin et al.
patent: 4859685 (1989-08-01), Jerussi et al.
patent: 4863918 (1989-09-01), Gala et al.
patent: 4871749 (1989-10-01), Lin et al.
patent: 4900738 (1990-02-01), Bagley et al.
patent: 4912109 (1990-03-01), Bagley et al.
patent: 4916142 (1990-04-01), Bagley et al.
patent: 4921864 (1990-05-01), Kudzma et al.
patent: 4939161 (1990-07-01), Lalinde et al.
patent: 4954506 (1990-09-01), Bagley et al.
patent: 4957929 (1990-09-01), Kudzma et al.
patent: 4994471 (1991-02-01), Lalinde et al.
patent: 5013742 (1991-05-01), Kudzma et al.
patent: 5015781 (1991-05-01), Robin et al.
patent: 5198449 (1993-03-01), Shanklin, Jr.
patent: 5290796 (1994-03-01), DeHaven-Hudkins et al.
patent: 5817678 (1998-10-01), Kim et al.
patent: 6451842 (2002-09-01), Shiota et al.
patent: 6635661 (2003-10-01), Cuny et al.
patent: 6645980 (2003-11-01), Cuny et al.
patent: 6677332 (2004-01-01), Cuny et al.
patent: 2003/0069418 (2003-04-01), Aquila et al.
patent: 2 340 874 (1974-02-01), None
patent: 0 160 422 (1985-11-01), None
patent: 0 256 798 (1988-02-01), None
patent: 0 261 842 (1988-03-01), None
patent: 0 277 794 (1988-08-01), None
patent: 0 333 427 (1989-09-01), None
patent: 0 343 900 (1989-11-01), None
patent: 394 039 (1990-10-01), None
patent: 0 396 282 (1990-11-01), None
patent: 0 466 585 (1992-01-01), None
patent: 2 338 043 (1977-08-01), None
patent: 2 729 142 (1996-07-01), None
patent: 1 382 526 (1975-02-01), None
patent: 1 382 965 (1975-02-01), None
patent: 02-138170 (1990-05-01), None
patent: 031 482 23 (1991-06-01), None
patent: 110 355 55 (1999-02-01), None
patent: WO89/04300 (1989-05-01), None
patent: WO 97/08155 (1997-03-01), None
patent: WO 97/18813 (1997-05-01), None
patent: WO 98/28275 (1998-07-01), None
patent: WO 99/24423 (1999-05-01), None
patent: WO 99/33806 (1999-07-01), None
patent: WO 00/06545 (2000-02-01), None
patent: WO 00/09491 (2000-02-01), None
patent: WO 00/023438 (2000-04-01), None
patent: WO 00/26186 (2000-05-01), None
patent: WO 00/27815 (2000-05-01), None
patent: WO 00/53596 (2000-09-01), None
patent: WO 00/71518 (2000-11-01), None
Stefan Van Den Branden et al. “Mimicking of Ergot Alkaloids and Synthetic Piperidine Druge 2.5-Substituted Piperidines Derived from Cis and Trans Ethyl 1-Benzyl-6-Cyano-3-Piperidinecarboxylate”, Tetrahedron 48 (44): 9753-9766 (1992).
Sternfeld et al.; “Synthesis and Serotonergic Activity of 3-[2-(Pyrrolidin-1-yl)ethyl] Indoles: Potent Agonist for the h5-HTIDReceptor with High Selectivity Over the h5-HTIBReceptor”, J. Med. Chem. 42: 677-690, (1999).
International Search Report made on PCT/US 00/ 14579, mailed on Nov. 29, 2000.
Harada et al.; “Development of Potent Seratonin-3 (5-HT3) Receptor Antagonists. I. Structure-Activity Relationships of 2-Alkoxy-4-amino-5-chlorobenzamide Derivatives”, Chem. Pharm. Bull.43 (8): 1364-1378 (1995).
Muro et al.; “115499q Preparation of (pyridycarbomoyl) Piperidine Derivatives as Cardiovascular Agents and Antihypertensives”, Chemical Abstracts, 107(13): 6001, (Sep. 28, 1987).
Welstead et al., Aminoalkylindoles With Central Nervous System Activity, P. D., 10: 1015-1021, (Nov. 1967).
Zheng et al.; “Design and Synthesis of Antiplatelet Nipecotamides with a Dual Mechanism of Action”, Medicinal Chemistry Research 7(4): 219-227, (1997).
International Search Report Completed on Jul. 12, 2002 and Mailed on Aug. 20, 2002.
Golovin et al.; “Synthesis of Substituted cis-3-aminoethyl-4-Hydroxypiperidines and Their acyl Derivatives”, Khim, Geterotsiki. Soedin, 10: 1363-8,(1978) CAS print out.
Carelli et al.; “Substituted N-(Pyridylmethyl) Anilides with Local Anesthetic Action”, Farmaco Ed. Sci. 16: 375-386, (1961); Chemical Abstracts Accession No. 1962: 31337, Document No. 56: 31337.
Kakefuda et al., An Efficient Synthesis of (+)-6,7-dimethyoxy-1-oxo-2-(3-piperidyl)-1,2,3,4-tetrahydroisoqunioline, Synthetic Communications, vol. 31, No. 3, pp. 401-408, 2001.
CAPLUS printout of COSTAKIS et al., Synthesis and Preliminary Pharmacological Study of some .alpha.-phenylalkylamines, Annales Pharmaceutiques Francaise, vol. 36, No. 7-8, pp. 349-360, 1978.
CAPLUS printout of PITRE et al., 1-Amino-1,3-diphenylethane Derivatives, Farmaco Edizione Scientifica, vol. 17, pp. 130-140, 1962.
Aquila Brian M.
Bannister Thomas D.
Cuny Gregory D.
Hauske James R.
Heffernan Michele L. R.
Coleman Brenda
Foley & Hoag LLP
Gordon Dana M.
Sepracor Inc.
LandOfFree
Heterocyclic analgesic compounds and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic analgesic compounds and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic analgesic compounds and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3629627